Replies to post #28239 on DNAprint Genomics (DNAG)

[jaber jaws]

anyone notice at closing bell 14,200,000 shares traded after close it went to 17,200,000 shares traded. did 3,ooo,ooo shares trade after close.

[loch3]

ice: It appears to me the exchange already took place at pre split value. The 8K uses the word "exchanged" (past tense) 25,000,000 shares.

[dr frudaky]

ice105

Are you sure about that post r/s scenario? You might be right because the pre r/s deal just does not make economic sense for Trace unless, of course, they ready to go belly-up anyway.

So at a 10 for 1 r/s, they would have received presplit 250 million, and at a 20 for 1 r/s, they would have received presplit 500 million. They also have the right to buy 5 million post split (50 or 100 million presplit) for .02?

If you are correct, then that Trace deal will cripple the current shareholder value. Add that to the Dutchess toxic financing and the company will probably need a 100 million revenue deal from a large pharma to help the shareholders get back anywhere near .02-.05/share, if that.

You have not even addressed the lucrative no cut, non performance based contracts which Frudakis will be giving those two clowns from Trace. You think they will accept anything less than what Gabriel and his wife got for doing no acquisition deal at all when they were first hired?

Inquiring minds would like answers to these questions. Gabriel must be upfront and honest at the meeting.

JMHO

dr f

[geob]

Hey ICE, AS STATED EARLIER.....

http://www.investorshub.com/boards/read_msg.asp?message_id=6174313

You should take the advice .....

of Jimmy Buffett .....

Get "Drunk and get Screwed" ....

CHEESE BURGER IN PARADISE---GEO

[worktoplay]

ice...I have always respected your opinions but must say this one appears off base. The BOD hasn't officially received authorization to consider an R/S, let alone execute an acquisition based on post split shares.

Besides, as Elmer has pointed out, using post split as the basis makes even less sense.

Do consider that the newspaper is already reporting that the value of the deal was $257,000. If Trace accepted an option at $0.02, they must feel there is reason to expect that the S/P will again see that level or higher. Of course, by the time it reaches $0.02, the original sale will be worth closer to $500,000, and so on and so forth...$250,000 for every penny rise in S/P.

Perhaps the folks at Trace, like many long shareholders, threw their lot in with DNAPrint with a view to the future value. In that sense, it could be either the smartest...or the dumbest...thing they've ever done...lol

JMHO,
W2P